Dose AI: GLP-1 Shot Tracker from TRIBE INDUSTRIES INC helps people prescribed GLP-1 medications keep to their treatment schedule and monitor effects. The app uses conversational AI to log meals, estimate macros, and record symptoms so users can see patterns across dosing cycles. Key tools include shot logging with site rotation, symptom tracking, progress charts, hydration tracking, and AI meal suggestions. It targets patients on GLP-1 therapies who need structured, day-to-day insight into medication, appetite, and progress.

What Dose AI does for GLP-1 treatment routines

Dose AI focuses on the weekly and daily rhythm of GLP-1 therapy, designed specifically for drugs such as Ozempic, Wegovy, and Mounjaro. It combines injection records, symptom entries, and progress visualizations so users can observe links between dosing and appetite or side effects. The app also includes logic for injection site rotation to address skin health and absorption concerns, which is a clinical need for regular injectors.

How the app accepts daily inputs on an iPhone

The app accepts meal and intake data via three concrete methods: photo recognition, barcode scanning, and natural language entry through a chat-like interface. It also supports optional photo check-ins and hydration logging to capture energy and appetite changes. Dose AI runs on iPhone and requires iOS 16.0 or later, so users should confirm device compatibility before relying on it for everyday tracking.

How reliable its daily insights and summaries are

Progress visualization displays weight and body-measurement trends alongside symptom timelines, helping users spot recurring triggers. The personalized meal assistant provides tailored suggestions for low-appetite days, and user feedback notes strong performance for the AI food logging and clarity when correlating dosing with hunger changes. These elements combine to produce actionable summaries rather than raw logs, suitable for routine self-monitoring.

What the app collects and its clinical limits for users

Dose AI gathers user-entered data such as meals, symptom reports, weights, measurements, and optional photos to generate insights; the tool is intended for tracking and educational purposes only and is not a medical device. The developer, TRIBE, positions the app as a companion rather than a diagnostic instrument, and the app includes prompts that encourage users to follow professional medical guidance when interpreting trends.

To sum up, Dose AI suits routine trackers but not clinical decision needs

Dose AI is a practical option for people on GLP-1 therapy who want clearer, day-to-day links between dosing, appetite, and symptoms; it helps surface patterns that are hard to see in a notebook. It is less appropriate for anyone seeking clinical decision support, since the app is explicitly for tracking and educational insights. Pro tip: record symptoms as they occur to make trend charts more informative.